中国实用内科杂志2023，Vol.43Issue(12)：972-977,6.DOI:10.19538/j.nk2023120102
急性肾损伤的生物标志物
Biomarkers of acute kidney injury
摘要
Abstract
Acute kidney injury(AKI)is a multifaceted syndrome caused by a variety of underlying diseases.Its high incidence and mortality rates render it a significant global health concern,which promotes a surge in research efforts worldwide focusing on AKI diagnosis and treatment.It is.substantial challenges for precise management of AKI,which is characterized by great difference in clinical manifestations.However,precise risk assessment and early diagnosis and treatment of AKI can potentially improve the prognosis of AKI patients.This article reviews the use of biomarkers in screening high AKI risk patients,facilitating early diagnosis and therapy,and assessing kidney recovery in current research.We also advocate for incorporating machine learning techniques in biomarker-based AKI research to promote precise implementation of biomarker-based AKI diagnosis and therapy.关键词
急性肾损伤/生物标志物/风险评估/诊断/肾脏恢复/人工智能Key words
acute kidney injury/biomarkers/risk assessment/diagnosis/kidney recovery/artificial intelligence分类
医药卫生引用本文复制引用
杨向红,孙仁华..急性肾损伤的生物标志物[J].中国实用内科杂志,2023,43(12):972-977,6.基金项目
浙江省科技厅重点研发计划项目(2019C03024) （2019C03024）
浙江省医药卫生重大科技计划项目(省部共建重点项目WKJ-ZJ-1811) （省部共建重点项目WKJ-ZJ-1811）
